View in EDS

Cost-Effectiveness of Tezepelumab Versus Omalizumab in Patients with Severe Uncontrolled Allergic Asthma in Spain.

Saved in:
Bibliographic Details
Title: Cost-Effectiveness of Tezepelumab Versus Omalizumab in Patients with Severe Uncontrolled Allergic Asthma in Spain.
Authors: Villamañan E; Department of Pharmacy, Hospital Universitario La Paz. IdiPaz, Madrid, Spain., Quirce S; Department of Allergy, Hospital Universitario La Paz. IdiPaz, Madrid, Spain., Torres C; AstraZeneca Farmacéutica Spain S.A., Madrid, Spain. covadonga.torres@astrazeneca.com., Martínez N; Doctoral Program in Biomedical Sciences and Public Health, International Doctorate Program, National University of Distance Education (UNED), Institute of Health Carlos III (IMIENS), Madrid, Spain., Garí C; Outcomes'10 (A ProductLife Group Company), Castellón de la Plana, Spain., Vidal-Vilar N; Outcomes'10 (A ProductLife Group Company), Castellón de la Plana, Spain., Almonacid C; Department of Respiratory Medicine, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Source: PharmacoEconomics - open [Pharmacoecon Open] 2026 Jul 01. Date of Electronic Publication: 2026 Jul 01.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Publishing AG Country of Publication: Switzerland NLM ID: 101700780 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2509-4254 (Electronic) Linking ISSN: 25094262 NLM ISO Abbreviation: Pharmacoecon Open
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42384129
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cost-Effectiveness of Tezepelumab Versus Omalizumab in Patients with Severe Uncontrolled Allergic Asthma in Spain.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Villamañan+E%22">Villamañan E</searchLink>; Department of Pharmacy, Hospital Universitario La Paz. IdiPaz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Quirce+S%22">Quirce S</searchLink>; Department of Allergy, Hospital Universitario La Paz. IdiPaz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Torres+C%22">Torres C</searchLink>; AstraZeneca Farmacéutica Spain S.A., Madrid, Spain. covadonga.torres@astrazeneca.com.<br /><searchLink fieldCode="AU" term="%22Martínez+N%22">Martínez N</searchLink>; Doctoral Program in Biomedical Sciences and Public Health, International Doctorate Program, National University of Distance Education (UNED), Institute of Health Carlos III (IMIENS), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Garí+C%22">Garí C</searchLink>; Outcomes'10 (A ProductLife Group Company), Castellón de la Plana, Spain.<br /><searchLink fieldCode="AU" term="%22Vidal-Vilar+N%22">Vidal-Vilar N</searchLink>; Outcomes'10 (A ProductLife Group Company), Castellón de la Plana, Spain.<br /><searchLink fieldCode="AU" term="%22Almonacid+C%22">Almonacid C</searchLink>; Department of Respiratory Medicine, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101700780%22">PharmacoEconomics - open</searchLink> [Pharmacoecon Open] 2026 Jul 01. <i>Date of Electronic Publication: </i>2026 Jul 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International+Publishing+AG%22">Springer International Publishing AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101700780 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2509-4254 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225094262%22">25094262 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacoecon Open
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42384129
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s41669-026-00667-6
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Cost-Effectiveness of Tezepelumab Versus Omalizumab in Patients with Severe Uncontrolled Allergic Asthma in Spain.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Villamañan E
      – PersonEntity:
          Name:
            NameFull: Quirce S
      – PersonEntity:
          Name:
            NameFull: Torres C
      – PersonEntity:
          Name:
            NameFull: Martínez N
      – PersonEntity:
          Name:
            NameFull: Garí C
      – PersonEntity:
          Name:
            NameFull: Vidal-Vilar N
      – PersonEntity:
          Name:
            NameFull: Almonacid C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2509-4254
          Titles:
            – TitleFull: PharmacoEconomics - open
              Type: main
ResultId 1